Balyasny Asset Management
URGN icon

Balyasny Asset Management’s UroGen Pharma URGN Stock Holding History

Balyasny Asset Management’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
2025
Q1 		$235K Sell
2024
Q4 		$261K Sell
2024
Q3 		$363K Sell
2024
Q2 		$2.92M Buy
2024
Q1 		$375K Buy
2022
Q4 		– Sell
2022
Q3 		$99K Buy